CytomX Therapeutics, Inc. (CTMX) has a market capitalization of $772.94M and trades at $4.54. The 52-week range is 0.4-8.21.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -30.3, Earnings Per Share (EPS) of $-0.15, annual revenue of $76.2M.
The stock has a beta of 2.48, operates in the Healthcare sector.
